Yanan Li

Title: Yanan Li: Innovator in Nano Small Peptide Research

Introduction

Yanan Li is a prominent inventor based in Wuhan, China, known for his significant contributions to the field of biotechnology. With a focus on developing innovative solutions for treating and preventing fundus vascular diseases, he has secured two patents that showcase his expertise and dedication to advancing medical science.

Latest Patents

Yanan Li's latest patents include the development of nano small peptides designed for drug preparation aimed at treating and preventing fundus vascular diseases. The first patent describes a nano small peptide FH with a molecular formula of X-FFVLK-KQKRPRH, where X can be dodecanoyl, tetradecanoyl, hexadecanoyl, or octadecanoyl. This peptide specifically targets receptors to encapsulate sSemaD protein, effectively reducing its concentration and preventing it from binding to receptors. This innovation addresses the limitations of existing antibody drugs by providing additional inhibitory targets. The second patent details a nano small peptide FG, which has a molecular formula of X-FFVLKKNKAAKG. Similar to the first, this peptide also targets sSema4D protein, reducing its concentration and enhancing the efficacy of antibody drugs without causing immune reactions.

Career Highlights

Throughout his career, Yanan Li has worked with notable companies such as Futu Biotech Co., Ltd. and Hubei Zhuzhao Biotechnology Co., Ltd. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in biotechnology.

Collaborations

Yanan Li has collaborated with esteemed colleagues, including Bo Hu and Hao Wang, who have played significant roles in his research endeavors. Their combined expertise has furthered the development of innovative solutions in the field of medical biotechnology.

Conclusion

Yanan Li's contributions to the field of biotechnology, particularly through his innovative nano small peptides, demonstrate his commitment to improving medical treatments for fundus vascular diseases. His work continues to inspire advancements in drug development and therapeutic strategies.